|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues, net | |||||
| Cost of revenues | |||||
| Cost of Revenues | |||||
| Restructuring charges | |||||
| Restructuring Related Charges | |||||
| Total cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Marketing and sales | |||||
| General and administrative | |||||
| Research and development | |||||
| Restructuring, impairment and other related charges | |||||
| Loss on impairment of goodwill | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other (expense) income: | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Loss on extinguishment of debt | |||||
| Change in fair value – warrant liabilities | |||||
| Total other (expense) income, net | |||||
| Net (loss) income before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net loss attributable to noncontrolling interest | |||||
| Net loss attributable to Purple Innovation, Inc. | |||||
| Net loss per share: | |||||
| Basic (in Dollars per share) | |||||
| Diluted (in Dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) | |||||
Loading...